{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:26:41Z","timestamp":1787905601361,"version":"build-2784847793"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ajp.2014.08.002","type":"journal-article","created":{"date-parts":[[2014,8,13]],"date-time":"2014-08-13T15:39:13Z","timestamp":1407944353000},"page":"3-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["Antipsychotic treatment of schizophrenia: An update"],"prefix":"10.1016","volume":"11","author":[{"given":"Dawn","family":"Bruijnzeel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Suryadevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2014.08.002_bib0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.schres.2013.04.027","article-title":"Logic and justification for dimensional assessment of symptoms and related phenomena in psychosis: relevance to DSM-5","volume":"150","author":"Barch","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2014.08.002_bib0010","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1176\/ps.2008.59.7.782","article-title":"Indicators of conformance with guidelines of schizophrenia treatment in mental health services","volume":"59","author":"Bollini","year":"2008","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.ajp.2014.08.002_bib0015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.pra.0000327312.04153.da","article-title":"Are second-generation antipsychotics a distinct class?","volume":"14","author":"Bonham","year":"2008","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.ajp.2014.08.002_bib0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/schbul\/sbp116","article-title":"The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements","volume":"36","author":"Buchanan","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ajp.2014.08.002_bib0025","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.3854","article-title":"Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs","volume":"192","author":"Creese","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.ajp.2014.08.002_bib0030","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1176\/appi.ajp.2008.08060806","article-title":"Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST)","volume":"166","author":"Davidson","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2014.08.002_bib0035","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/JCP.0b013e3181d2193c","article-title":"Antipsychotic drug treatment in first-episode psychosis","volume":"30","author":"Derks","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2014.08.002_bib0040","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1176\/ajp.2006.163.4.743","article-title":"Time course for antipsychotic treatment response in first-episode schizophrenia","volume":"163","author":"Emsley","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2014.08.002_bib0045","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000135641","article-title":"Typical and atypical antipsychotics \u2013 the misleading dichotomy","volume":"57","author":"Fischer-Barnicol","year":"2008","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.ajp.2014.08.002_bib0050","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/bmj.321.7273.1371","article-title":"Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis","volume":"231","author":"Geddes","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.ajp.2014.08.002_bib0055","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archpsyc.1995.03950150005001","article-title":"Neuroleptic withdrawal in schizophrenic patients. A review of the literature","volume":"52","author":"Gilbert","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2014.08.002_bib0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/schbul\/sbp136","article-title":"Catatonia in the DSM \u2013 shall we move or not?","volume":"36","author":"Heckers","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ajp.2014.08.002_bib0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.schres.2013.04.039","article-title":"Structure of the psychotic disorders classification in DSM-5","volume":"150","author":"Heckers","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2014.08.002_bib0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1586\/ern.09.143","article-title":"Effect of second-generation antipsychotics on cognition: current issues and future challenges","volume":"10","author":"Hill","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ajp.2014.08.002_bib0075","doi-asserted-by":"crossref","first-page":"897","DOI":"10.4088\/JCP.v67n0606","article-title":"Haloperidol dose when used as active comparator in randomized controlled trials with atypical antipsychotics in schizophrenia: comparison with officially recommended doses","volume":"67","author":"Hugenholtz","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2014.08.002_bib0080","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(78)90193-9","article-title":"Mechanism of antipsychotic effect in the treatment of acute schizophrenia","volume":"1","author":"Johnstone","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2014.08.002_bib0085","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","article-title":"Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomized clinical trial","volume":"371","author":"Kahn","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2014.08.002_bib0090","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2014.08.002_bib0095","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0006-3223(01)01251-3","article-title":"Dopamine D2 receptors and their role in antipsychotic action: still necessary and may even be sufficient","volume":"50","author":"Kapur","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2014.08.002_bib0100","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archpsyc.64.6.633","article-title":"Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial","volume":"64","author":"Keefe","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2014.08.002_bib0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.schres.2008.07.020","article-title":"Schizophrenia, \u201cJust the Facts\u201d. What we know in 2008. Part 3: Neurobiology","volume":"106","author":"Keshavan","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2014.08.002_bib0110","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/npp.2009.164","article-title":"Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia","volume":"35","author":"Kinon","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ajp.2014.08.002_bib0115","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/schbul\/sbp130","article-title":"The schizophrenia patient outcomes research team (PORT) recommendations, 2009","volume":"36","author":"Kreyenbuhl","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ajp.2014.08.002_bib0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2014.08.002_bib0125","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.mp.4002136","article-title":"How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials","volume":"14","author":"Leucht","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ajp.2014.08.002_bib0130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1176\/appi.ajp.2008.08030368","article-title":"A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia","volume":"166","author":"Leucht","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2014.08.002_bib0135","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(12)60239-6","article-title":"Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis","volume":"379","author":"Leucht","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2014.08.002_bib0140","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2014.08.002_bib0145","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/schbul\/sbj067","article-title":"Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia","volume":"32","author":"Lewis","year":"2006","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ajp.2014.08.002_bib0150","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ajp.2014.08.002_bib0155","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1176\/appi.ajp.161.8.1334","article-title":"Physical health monitoring of patients with schizophrenia","volume":"161","author":"Marder","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2014.08.002_bib0160","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.2006.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior antipsychotic treatment","volume":"163","author":"McEvoy","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2014.08.002_bib0165","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0447.2006.00982.x","article-title":"The case for long-acting antipsychotic agents in the post-CATIE era","volume":"115","author":"Nasrallah","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ajp.2014.08.002_bib0170","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1176\/appi.ps.56.3.273","article-title":"Defining and measuring clinical effectiveness in the treatment of schizophrenia","volume":"56","author":"Nasrallah","year":"2005","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.ajp.2014.08.002_bib0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/11530250-000000000-00000","article-title":"Progress in defining optimal treatment outcome in schizophrenia","volume":"24","author":"Remington","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ajp.2014.08.002_bib0180","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2165\/11314280-000000000-00000","article-title":"Antipsychotic drugs for first-episode schizophrenia: a comparative review","volume":"23","author":"Salimi","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ajp.2014.08.002_bib0185","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ajp.2014.08.002_bib0190","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1192\/bjp.bp.107.037184","article-title":"First- v. second- generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis","volume":"196","author":"Smith","year":"2008","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ajp.2014.08.002_bib0195","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/ajp.2007.164.3.428","article-title":"Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study","volume":"164","author":"Swartz","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2014.08.002_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4088\/JCP.10075su1.01","article-title":"Antipsychotics in the treatment of schizophrenia","volume":"72","author":"Tandon","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2014.08.002_bib0205","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.psc.2012.06.001","article-title":"The nosology of schizophrenia: towards DSM-5 and ICD-11","volume":"35","author":"Tandon","year":"2012","journal-title":"Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.ajp.2014.08.002_bib0210","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/schbul\/sbs048","article-title":"DSM-5 status of psychotic disorders","volume":"38","author":"Tandon","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ajp.2014.08.002_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4530(02)00109-9","article-title":"The second-generation \u2018atypical\u2019 antipsychotics: Similar improved efficacy but different neuroendocrine side-effects","volume":"28","author":"Tandon","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ajp.2014.08.002_bib0220","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ajp.2008.10.002","article-title":"Nosological status and definition of schizophrenia","volume":"1","author":"Tandon","year":"2008","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.ajp.2014.08.002_bib0225","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archpsyc.63.8.935","article-title":"Subjecting meta-analyses to closer scrutiny: little support for differential efficacy among second-generation antipsychotics. The author's reply","volume":"63","author":"Tandon","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2014.08.002_bib0230","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0920-9964(99)00163-2","article-title":"Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcome","volume":"45","author":"Tandon","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2014.08.002_bib0235","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/13651500510029192","article-title":"Comparing efficacy of first-line atypical antipsychotics. No evidence of differential efficacy","volume":"9","author":"Tandon","year":"2005","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.ajp.2014.08.002_bib0240","first-page":"348","article-title":"Strategies for maximizing clinical effectiveness in the treatment of schizophrenia","volume":"12","author":"Tandon","year":"2006","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.ajp.2014.08.002_bib0245","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.psychres.2005.05.006","article-title":"Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder","volume":"136","author":"Tandon","year":"2006","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ajp.2014.08.002_bib0250","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2008.01.022","article-title":"Schizophrenia, \u201cJust the Facts\u201d. What we know in 2008. Part 1: Overview","volume":"100","author":"Tandon","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2014.08.002_bib0255","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2007.11.033","article-title":"World Psychiatry Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia","volume":"100","author":"Tandon","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2014.08.002_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2009.03.005","article-title":"Schizophrenia, \u201cJust the facts\u201d 4. Clinical features and conceptualization","volume":"110","author":"Tandon","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2014.08.002_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2010.05.025","article-title":"Schizophrenia, \u201cJust the facts\u201d 5. Treatment and prevention","volume":"122","author":"Tandon","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2014.08.002_bib0270","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.schres.2013.05.028","article-title":"Schizophrenia in the DSM-5","volume":"150","author":"Tandon","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2014.08.002_bib0275","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.schres.2013.04.034","article-title":"Catatonia in the DSM-5","volume":"150","author":"Tandon","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2014.08.002_bib0280","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1053\/comp.2001.24577","article-title":"Depression in patients with schizophrenia during an acute psychotic episode","volume":"42","author":"Tapp","year":"2001","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.ajp.2014.08.002_bib0285","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/NDT.S41063","article-title":"Unmet needs in the management of schizophrenia","volume":"10","author":"Torres-Gonzalez","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.ajp.2014.08.002_bib0290","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.schres.2013.05.004","article-title":"Attenuated psychosis syndrome in DSM-5","volume":"15","author":"Tsuang","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2014.08.002_bib0295","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-003-1648-y","article-title":"Neuroleptic dysphoria: towards a new synthesis","volume":"171","author":"Voruganti","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ajp.2014.08.002_bib0300","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00131746-200701000-00003","article-title":"EPS profiles: the atypical antipsychotics are not all the same","volume":"13","author":"Weiden","year":"2007","journal-title":"J. Psychiatric Pract."},{"key":"10.1016\/j.ajp.2014.08.002_bib0305","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jamapsychiatry.2013.19","article-title":"Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction\/discontinuation or maintenance strategy","volume":"70","author":"Wunderink","year":"2013","journal-title":"JAMA Psychiatry"}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201814001907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201814001907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:24:11Z","timestamp":1761755051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201814001907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":61,"alternative-id":["S1876201814001907"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2014.08.002","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotic treatment of schizophrenia: An update","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2014.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}